Publications

5808 Results

A multi center trial of hyperCVAD+rituxan in patients with newly diagnosed mantle cell lymphoma

Authors
EM Epner;J Unger;T Miller;L Rimsza;C Spier;M LeBlanc;R Fisher
Journal / Conference
Blood 110(11):#387
Year
2007
Research Committee(s)
Lymphoma
Study Number(s)
S0213

Numbers of lymphoma associated macrophages (LAMS) and regulatory T-cells (Tregs) in follicular lymphoma (FL) patients (pts) treated with and without monoclonal antibody (MoAb)-containing therapy do not correlate with overall survival (OS): a study from the Southwest Oncology Group (SWOG)

Authors
JW Sweetenham;E Hsi;B Goldman;M LeBlanc;RR Tubbs;JR Cook;OW Press;RI Fisher;LM Rimsza
Journal / Conference
Blood 110(11):#2602
Year
2007
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8809, S9911

Expression of the microtubule-associated protein, tau, predicts improved survival, but not response, to a combination of docetaxel and vinorelbine in HER-2 negative metastatic breast cancer

Authors
JR Gralow;WE Barlow;AM Gown;LC Goldstein;PL Porter;IT Yeah;RB Livingston;RB Livingston;DF Hayes
Journal / Conference
San Antonio Breast Cancer Symposium #2015
Year
2007
Research Committee(s)
Breast
Study Number(s)
S0102

Vorinostat (suberoylanilide hydroxamic acid) in relapsed or refractory Hodgkin lymphoma: SWOG 0517

Authors
MH Kirschbaum;BH Goldman;JM Zain;JR Cook;LM Rimsza;SJ Forman;RI Fisher
Journal / Conference
Blood 110(11):#2574
Year
2007
Research Committee(s)
Lymphoma
Study Number(s)
S0517

Phase II studies of different schedules and doses of the farnesyl transferase inhibitor tipifarnib (R115777, Zarnestra, NSC-702818) for patients of age 70 or older with previously untreated acute myeloid leukemia (AML): A North American Intergroup study (S0432)

Authors
HP Erba;KJ Kopecky;MH Kirschbaum;MS Tallman;RA Larson;CL Willman;ML Slovak;HM Gundacker;FR Appelbaum
Journal / Conference
Blood 110(11):#440
Year
2007
Research Committee(s)
Leukemia
Study Number(s)
S0432

Superiority of lenalidomide (Len) plus high-dose dexamethasone (HD) compared to HD alone as treatment of newly-diagnosed multiple myeloma (NDMM): results of the randomized, double-blinded, placebo-controlled SWOG trial S0232

Authors
JA Zonder;J Crowley;MA Hussein;V Bolejack;DF Moore Sr;BP Whittenberger;MH Abidi;BGM Durie;B Barlogie
Journal / Conference
Blood 110(11):#77
Year
2007
Research Committee(s)
Myeloma
Study Number(s)
S0232

Central nervous system (CNS) relapse in agressive non-Hodgkin's lymphoma; does CNS prophylaxis work?

Authors
SH Bernstein;J Unger;M LeBlanc;RI Fisher
Journal / Conference
Blood 110(11):#520
Year
2007
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8516 (INT-0067)

Phase II pilot study of rituximab + CHOP in patients with newly diagnosed Waldenstrom's macroglobulinemia, an Eastern Cooperative Oncology Group trial (study E1A02)

Authors
R Abonour;LA Zhang;V Rajkumar;G Srkalovic;PR Greipp;R Fonseca;M Gertz
Journal / Conference
Blood 110(11):#3616
Year
2007
Research Committee(s)
Myeloma
Study Number(s)
E1A02

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal, node-negative, ER-positive breast cancer (S8814, INT0100)

Authors
K Albain;W Barlow;S Shak;G Hortobagyi;R Livingston;I Yeh;P Ravdin;C Yoshizawa;F Baehner;N Davidson;G Sledge;E Winer;C Hudis;J Ingle;E Perez;K Pritchard;L Shepherd;C Allred;K Osborne;D Hayes
Journal / Conference
San Antonio Breast Cancer Symposium #10
Year
2007
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials [PMID17197435]

Authors
N Kuptsova;KJ Kopecky;J Godwin;J Anderson;A Hoque;CL Willman;ML Slovak;CB Ambrosone
Journal / Conference
Blood 109(9):3936-3944
Year
2007
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031, SWOG-9333